نتائج البحث - "Simone M. Goldinger"

1

Long-Term Response to Intermittent Binimetinib in Patients with NRAS-Mutant Melanoma

المؤلفون: Alexandra Valeska Matter, Simone M. Goldinger, Sara Micaletto, Ursula Urner-Bloch, Reinhard Dummer

المساهمون: University of Zurich, Dummer, Reinhard

المصدر: The Oncologist

مصطلحات موضوعية: Male, Proto-Oncogene Proteins B-raf, 0301 basic medicine, Neuroblastoma RAS viral oncogene homolog, MAPK/ERK pathway, Cancer Research, Skin Neoplasms, medicine.medical_treatment, 610 Medicine & health, Drug resistance, GTP Phosphohydrolases, Targeted therapy, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Immune system, Cell Line, Tumor, Humans, Medicine, 1306 Cancer Research, Melanoma, Protein Kinase Inhibitors, Aged, business.industry, Kinase, 10177 Dermatology Clinic, Membrane Proteins, Binimetinib, medicine.disease, 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, Mutation, Cancer research, 2730 Oncology, Precision Medicine Clinic: Molecular Tumor Board, Benzimidazoles, Female, business

وصف الملف: 855_Matter_A._et_al._Long-Term_response_to_intermittent_binimetinib_in_patients_with_NRAS-mutant_Melanoma_the_Oncologist_2020.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::145601bc949f4b0f83188d4b388aa2acTest
https://doi.org/10.1634/theoncologist.2019-0656Test

2

Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma

المؤلفون: Nadia Plantier, Sabrina A. Hogan, Simone M. Goldinger, Marieke I.G. Raaijmakers, Anais Courtier, Jean-François Mouret, Thi Dan Linh Nguyen-Kim, Phil F. Cheng, John B. A. G. Haanen, Mitchell P. Levesque, Solène Perez, Pia Kvistborg, Reinhard Dummer, Nicoletta F Jaberg-Bentele, Manuarii Manuel, Nicolas Pasqual

المساهمون: University of Zurich, Levesque, Mitchell P

المصدر: Cancer Immunology Research

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Immunology, Receptors, Antigen, T-Cell, 610 Medicine & health, chemical and pharmacologic phenomena, Antibodies, Monoclonal, Humanized, Peripheral blood mononuclear cell, 03 medical and health sciences, symbols.namesake, Antineoplastic Agents, Immunological, 0302 clinical medicine, Internal medicine, medicine, Humans, CTLA-4 Antigen, 1306 Cancer Research, Progression-free survival, Melanoma, Fisher's exact test, Aged, 2403 Immunology, Receiver operating characteristic, 10042 Clinic for Diagnostic and Interventional Radiology, business.industry, T-cell receptor, 10177 Dermatology Clinic, Immunotherapy, Middle Aged, medicine.disease, Ipilimumab, Progression-Free Survival, 3. Good health, 030104 developmental biology, 030220 oncology & carcinogenesis, Monoclonal, symbols, Female, business

وصف الملف: Peripheral_blood_TCR_repertoire_profiling_may_facilitate.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2183a0c56e9ee4715bc5ea53f32f0b44Test
https://doi.org/10.1158/2326-6066.cir-18-0136Test

3

Sarcoid-like reactions in patients receiving modern melanoma treatment

المؤلفون: Joanna Mangana, Mirjam C. Naegeli, Marjam J. Barysch, Simone M. Goldinger, Ralph P. Braun, Anna L. Frauchiger, Daniel Franzen, Mirjana Urosevic-Maiwald, Jivko Kamarachev, Reinhard Dummer, Florentia Dimitriou

المساهمون: University of Zurich, Dummer, Reinhard

المصدر: Melanoma Research

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Sarcoidosis, medicine.medical_treatment, Programmed Cell Death 1 Receptor, 610 Medicine & health, Dermatology, Disease, Targeted therapy, 2708 Dermatology, 030207 dermatology & venereal diseases, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Immune system, Cancer immunotherapy, medicine, melanoma, Humans, 1306 Cancer Research, Adverse effect, Protein Kinase Inhibitors, Aged, Retrospective Studies, business.industry, Melanoma, 10177 Dermatology Clinic, Retrospective cohort study, Middle Aged, medicine.disease, ORIGINAL ARTICLES: Clinical research, targeted therapy, Oncology, 030220 oncology & carcinogenesis, sarcoid-like reaction, 2730 Oncology, Immunotherapy, 10178 Clinic for Pneumology, business

وصف الملف: 755_Dimitriou_F._et_al._Sarcoid-like_reactions_in_patients_receiving_modern_melanoma_treatment_Melanoma_Res._2018.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::338a9ad98b357f816497b9c7ee261928Test
http://europepmc.org/articles/PMC5929490Test

4

Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching?

المؤلفون: Silvia A. Haueis, Ralph P. Braun, Mitchell P. Levesque, Simone M. Goldinger, Mirjana Urosevic-Maiwald, Joanna Mangana, Phil F. Cheng, Pascale Kränzlin, Reinhard Dummer

المساهمون: University of Zurich, Goldinger, Simone M

المصدر: Melanoma Research. 27:231-237

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Pathology, BRAF inhibitor, medicine.medical_treatment, Targeted therapy, 0302 clinical medicine, Modified recist, 1306 Cancer Research, Melanoma, Aged, 80 and over, Brain Neoplasms, 10177 Dermatology Clinic, Neoplasms, Second Primary, Middle Aged, Prognosis, Phenotype, Survival Rate, 030220 oncology & carcinogenesis, Distribution pattern, Disease Progression, 2730 Oncology, Female, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, 610 Medicine & health, Dermatology, 2708 Dermatology, Young Adult, 03 medical and health sciences, Text mining, Internal medicine, medicine, Humans, Neoplasm Invasiveness, In patient, Protein Kinase Inhibitors, Aged, Retrospective Studies, business.industry, medicine.disease, 030104 developmental biology, Case-Control Studies, business, Follow-Up Studies

وصف الملف: 684_Haueis_S._et_al._Does_the_distribution_pattern_of_brain_metastases_during_BRAF_Melanoma_Res._2017.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d8487ec9a6452542b2955e97293575dTest
https://doi.org/10.1097/cmr.0000000000000338Test

5

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity:clinical outcomes in advanced melanoma

المساهمون: Surgery, Faculty of Medicine and Pharmacy, Clinical sciences, Medical Oncology, Laboratory for Medical and Molecular Oncology, Laboratory of Molecullar and Cellular Therapy, HUS Comprehensive Cancer Center, Department of Oncology, University of Helsinki, University of Zurich, Jansen, Y J L

المصدر: Jansen, Y J L, Rozeman, E A, Mason, R, Goldinger, S M, Geukes Foppen, M H, Højberg, L, Schmidt, H, van Thienen, J V, Haanen, J B A G, Tiainen, L, Svane, I M, Mäkelä, S, Seremet, T, Arance, A, Dummer, R, Bastholt, L, Nyakas, M, Straume, O, Menzies, A M, Long, G V, Atkinson, V, Blank, C U & Neyns, B 2019, ' Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity : clinical outcomes in advanced melanoma ', Annals of Oncology, vol. 30, no. 7, pp. 1154-1161 . https://doi.org/10.1093/annonc/mdz110Test
Jansen, Y J L, Rozeman, E A, Mason, R, Goldinger, S M, Geukes Foppen, M H, Hoejberg, L, Schmidt, H, Van Thienen, J V, Haanen, J B A G, Tiainen, L, Svane, I M, Mäkelä, S, Seremet, T, Arance, A, Dummer, R, Bastholt, L, Nyakas, M, Straume, O, Menzies, A M, Long, G V, Atkinson, V, Blank, C U & Neyns, B 2019, ' Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity : clinical outcomes in advanced melanoma ', Annals of Oncology, vol. 30, no. 7, mdz110, pp. 1154-1161 . https://doi.org/10.1093/annonc/mdz110Test
Jansen, Y J L, Rozeman, E A, Mason, R, Goldinger, S M, Geukes Foppen, M H, Hoejberg, L, Schmidt, H, Van Thienen, J V, Haanen, J B A G, Tiainen, L, Svane, I M, Mäkelä, S, Seremet, T, Arance, A, Dummer, R, Bastholt, L, Nyakas, M, Straume, O, Menzies, A M, Long, G V, Atkinson, V, Blank, C U & Neyns, B 2019, ' Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity : clinical outcomes in advanced melanoma ', Annals of Oncology, vol. 30, no. 7, pp. 1154-1161 . https://doi.org/10.1093/annonc/mdz110Test

مصطلحات موضوعية: Male, 0301 basic medicine, Skin Neoplasms, Programmed Cell Death 1 Receptor, 2720 Hematology, MONOTHERAPY, Pembrolizumab, Gastroenterology, Cohort Studies, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Prospective Studies, Aged, 80 and over, anti-PD-1 therapy, 10177 Dermatology Clinic, Hematology, Middle Aged, Evaluable Disease, Prognosis, Substance Withdrawal Syndrome, 3. Good health, Survival Rate, Nivolumab, Oncology, SAFETY, 030220 oncology & carcinogenesis, Cohort, Disease Progression, SURVIVAL, Female, 2730 Oncology, immunotherapy, duration of treatment, Cohort study, medicine.drug, Adult, medicine.medical_specialty, 3122 Cancers, 610 Medicine & health, Ipilimumab, Antibodies, Monoclonal, Humanized, PROFILE, 03 medical and health sciences, Internal medicine, melanoma, medicine, Humans, PEMBROLIZUMAB, Aged, Retrospective Studies, business.industry, IPILIMUMAB, Discontinuation, Clinical trial, 030104 developmental biology, COMBINED NIVOLUMAB, business, Follow-Up Studies

وصف الملف: application/pdf; 811_Jansen_Y._et_al._Discontinuation_of_anti-PD-1_antibody_therapy_in_the_absence_of_disease_progression_or_treatment_limiting_toxicity_etc._Annals_of_Oncology_2019.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acb2426cfdad8323d67c5bd20e80a59eTest
https://curis.ku.dk/portal/da/publications/discontinuation-of-antipd1-antibody-therapy-in-the-absence-of-disease-progression-or-treatment-limiting-toxicityTest(00dd1bed-a3b3-45b5-b8d4-f911468c6499).html

6

Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case report

المؤلفون: Lars E. French, Simone M. Goldinger, Reinhard Dummer, Pascale Kränzlin-Stieger, Carla Murer

المساهمون: University of Zurich, Murer, Carla

المصدر: Melanoma Research. 27:396-398

وصف الملف: 702_Murer_C._et_al._Successful_treatment_with_imatinib_after_nilotinib_and_ipilimumab_in_a_Melanoma_Res._2017.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f877a2c640b7cb849a1e1f4ace3d08Test
https://doi.org/10.1097/cmr.0000000000000358Test

7

The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe

المؤلفون: Sara Micaletto, Egle Ramelyte, Regina Krattinger, Reinhard Dummer, Marjam J. Barysch, Simone M. Goldinger, Florentia Dimitriou

المساهمون: University of Zurich, Goldinger, Simone M

المصدر: Current Oncology Reports. 20

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f75a4eb0ee41498d67e0b2b49f5c37afTest
https://doi.org/10.1007/s11912-018-0732-8Test

8

Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy

المساهمون: University of Zurich, Heinzerling, Lucie M

المصدر: European Journal of Cancer. 60:210-225

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Eye Diseases, Heart Diseases, Programmed Cell Death 1 Receptor, Respiratory Tract Diseases, Medizin, 610 Medicine & health, Antineoplastic Agents, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Humans, Medicine, 1306 Cancer Research, Musculoskeletal Diseases, Adverse effect, Melanoma, Aged, Retrospective Studies, business.industry, 10177 Dermatology Clinic, Antibodies, Monoclonal, Cancer, Cell Cycle Checkpoints, Middle Aged, medicine.disease, Myasthenia gravis, Nivolumab, 030220 oncology & carcinogenesis, Immunology, 2730 Oncology, Female, Nervous System Diseases, Skin cancer, business, 030217 neurology & neurosurgery, medicine.drug

وصف الملف: 657_Zimmer L. et al._Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD1 Therapy_EJC 2016.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a1556fdca6ff1cf1a91650c07c15aefTest
https://doi.org/10.1016/j.ejca.2016.02.024Test

9

Pyogenic granuloma in patients treated with selective BRAF inhibitors: another manifestation of paradoxical pathway activation

المؤلفون: Pascale Stieger, Simone M. Goldinger, Reinhard Dummer, Jivko Kamarachev, Benjamin Henning

المساهمون: University of Zurich, Goldinger, Simone M

المصدر: Melanoma Research. 26:304-307

وصف الملف: 656_Hofmann L. et al._Cutaneous, gastrointestinal, hepatic, endocrine and renal side-effects of anti-PD1 therapy_EJC 2016.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ab28e0e8bd4c37ee80b230751efa101Test
https://doi.org/10.1097/cmr.0000000000000248Test

10

Efficacy and safety of oral alitretinoin in severe oral lichen planus - results of a prospective pilot study

المؤلفون: Antonio Cozzio, Mirjana Urosevic-Maiwald, Anna L. Frauchiger, Simone M. Goldinger, Lars E. French, Daniella Jenni, Jivko Kamarachev, Michael Kunz, M. Dippel, Benedetta Belloni, Emmanuella Guenova, J. Mangana, Jil Dreier, Reinhard Dummer

المساهمون: University of Zurich, Dummer, R

المصدر: Journal of the European Academy of Dermatology and Venereology. 30:293-298

مصطلحات موضوعية: Male, medicine.medical_specialty, Time Factors, Administration, Oral, Antineoplastic Agents, Pilot Projects, Tretinoin, 610 Medicine & health, Dermatology, Severity of Illness Index, 2708 Dermatology, 030207 dermatology & venereal diseases, 03 medical and health sciences, Alitretinoin, 0302 clinical medicine, Recurrence, Severity of illness, medicine, Clinical endpoint, Humans, Prospective Studies, Adverse effect, Prospective cohort study, Dose-Response Relationship, Drug, business.industry, Standard treatment, Mouth Mucosa, 10177 Dermatology Clinic, 2725 Infectious Diseases, 030206 dentistry, Middle Aged, medicine.disease, Surgery, Clinical trial, stomatognathic diseases, Retinoid X Receptors, Treatment Outcome, Infectious Diseases, Female, Oral lichen planus, business, Follow-Up Studies, Lichen Planus, Oral, medicine.drug

وصف الملف: 620_Kunz M. et al._Efficacy and safety of oral alitretinoin in severe oral lichen planus_JEADV 2015.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74da6304e63543d9f0741491ec737f2aTest
https://doi.org/10.1111/jdv.13444Test

تنقيح النتائج